49IA Hsbc Bk.22

RNS No 9513k
PACIFIC DUNLOP LIMITED
16th June 1998

PROPOSED SETTLEMENT IN AUSTRALIAN CLASS ACTION

Pacific Dunlop Limited today announced that agreement in prinipal had been
reached by the Group's insurers to settle certain current and future litigation
in Australia arising out of the Accufix Atrial "J" pacemaker leads formerly
manufactured by Accufix Research Institute (ARI) (then called Telectronics).
The settlement is subject to the approval of the Federal Court in Sydney - a
hearing for this purpose has been scheduled for 7th August, 1998.

The Court today ordered that all Australian patients with Accufix pacemaker
leads be notified on or before 30th June, 1998, by notice and press
advertisement of the terms of the proposed settlement and the date of the August
hearing.

The proposed settlement calls for the payment of $15,000 to those patients whose
Accufix pacemaker leads have been or will be explanted.  Explanted patients who
believe they are entitled to further compensation will be entitled to have their
claims assessed by a panel of two barristers.

The proposed settlement does not resolve the separate claims for compensation
for patients with working leads (the "monitoring class").  The defendants
continue to meet the unreimbursed medical expenses of the monitoring class, but
have been advised that this class intends to press litigation seeking monetary
compensation.  This suit will be vigorously defended.

For further information:      John Hine
                              General Manager Corporate Affairs
                              61 3 9270 7140
                              61 0412 254952

                              Martin Hudson
                              Chief General Counsel
                              61 3 9270 7102

END

MSCAVONKWRKNAAR

Hsbc Bk.22 (LSE:49IA)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Hsbc Bk.22 (LSE:49IA)
Historical Stock Chart
Von Jul 2023 bis Jul 2024